Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Chubb
Medtronic
Cipla
Deloitte
Daiichi Sankyo
Colorcon
QuintilesIMS
Argus Health

Generated: May 22, 2018

DrugPatentWatch Database Preview

COLCRYS Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Colcrys, and when can generic versions of Colcrys launch?

Colcrys is a drug marketed by Takeda Pharms Usa and is included in one NDA. There are seventeen patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in COLCRYS is colchicine. There are sixteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the colchicine profile page.
Drug patent expirations by year for COLCRYS
Pharmacology for COLCRYS
Medical Subject Heading (MeSH) Categories for COLCRYS
Synonyms for COLCRYS
(+-)-COLCHICINE
(S)-colchicin
(S)-colchicina
(S)-colchicine
(S)-N-(1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide
(S)-N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl) acetamide
(S)-N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)acetamide
078C484
24218-EP2275412A1
24218-EP2277865A1
24218-EP2281815A1
24218-EP2301933A1
24218-EP2301940A1
24218-EP2305219A1
24218-EP2305640A2
24218-EP2311827A1
24218-EP2314590A1
30512-31-3
3B1-006030
4lzr
4o2b
5843-86-7
64-86-8
7-alpha-H-Colchicine
7.alpha.H-Colchicine
7alphaH-Colchicine
AB2000548
AC1L1LXO
Acetamide, N-((7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-
Acetamide, N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-, (S)-
Acetamide, N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(alpha)heptalen-7-yl)-
Acetamide, N-[(7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl]-
Acetamide,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(.alpha.)heptalen-7-yl)-
Acetamide,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[.alpha.]heptalen-7-yl)-
Acetamide,N-[(7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl]-
ACon1_000353
AI3-31149
AKOS001582887
AN-16005
API0002098
AS-13686
BB_NC-0737
BDBM50014846
Benzo(a)heptalen-9(5H)-one
Benzo(a)heptalen-9(5H)-one, 7-acetamido-6,7-dihydro-1,2,3,10-tetramethoxy-
Benzo[a]heptalen-9(5H)-one,7-dihydro-1,2,3,10-tetramethoxy-
BG0155
binds to tubulin
binds to tubulin; inhibits microtubular assembly
BPBio1_000535
BRD-K00259736-001-06-5
BSPBio_000485
BSPBio_002083
BT000683
C 9754
C-21700
C-7100
C07592
C22H25NO6
CAS-64-86-8
CC-25958
CCG-39910
CCRIS 691
CHEBI:27882
CHEMBL107
CJ-04376
Colchicin
Colchicin [German]
Colchicina
Colchicina [Italian]
colchicine
Colchicine (JP15/USP)
Colchicine (JP17/USP)
Colchicine (TN)
Colchicine [JAN]
Colchicine [USP:JAN]
Colchicine for system suitability, European Pharmacopoeia (EP) Reference Standard
Colchicine, (+-)-Isomer
Colchicine, (European Pharmacopoeia (EP) Reference Standard)
Colchicine, (R)-Isomer
Colchicine, >=95% (HPLC), powder
Colchicine, >=96.0% (HPLC)
Colchicine, 95% dry weight 1g
Colchicine, BioReagent, plant cell culture tested, >=95% (HPLC)
Colchicine, Colchicum autumnale
Colchicine, pharmaceutical secondary standard; traceable to USP, PhEur, BP
Colchicine, United States Pharmacopeia (USP) Reference Standard
Colchicinum
Colchineos
Colchineos;Colchisol;Colcin
Colchisol
Colchysat
Colcin
Colsaloid
Colstat
Condylon
CS-1141
D00570
D09DHY
DB08117
DivK1c_000753
DR002336
DSSTox_CID_4845
DSSTox_GSID_24845
DSSTox_RID_77551
DTXSID5024845
EBD2156734
EINECS 200-598-5
EU-0100310
FT-0603187
Goutnil
GTPL2367
HE066732
HMS1569I07
HMS1920A08
HMS2091G16
HMS2096I07
HMS2231C05
HMS3260N22
HMS502F15
HSDB 3044
HY-16569
IAKHMKGGTNLKSZ-INIZCTEOSA-N
IDI1_000753
inhibits microtubular assembly
J10109
KBio1_000753
KBio2_001322
KBio2_003890
KBio2_006458
KBio3_001303
KBioGR_000856
KBioSS_001322
KM0881
Kolkicin
LOC
Lopac0_000310
LP00310
LS-279
M01514
MCULE-1568647156
MCULE-7858118731
MEGxp0_001879
MFCD00078484
MLS001055448
MLS001055448-02
MLS001304089
MLS002153786
MolPort-001-742-594
MPC-004
N-((7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)- acetamide
N-((7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-acetamide
N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)acetamide
N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[.alpha.]heptalen-7-yl)-acetamide
N-[(10S)-3,4,5,14-tetramethoxy-13-oxotricyclo[9.5.0.0?,?]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]ethanimidic acid
N-[(10S)-3,4,5,14-TETRAMETHOXY-13-OXOTRICYCLO[9.5.0.0(2),?]HEXADECA-1(16),2(7),3,5,11,14-HEXAEN-10-YL]ACETAMIDE
N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide
N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide;
N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[d]heptalen-7-yl]acetamide
N-[(7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl]acetamide
N-Acetyl trimethylcolchicinic acid methylether
N1721
NCGC00025125-01
NCGC00025125-02
NCGC00025125-03
NCGC00025125-04
NCGC00025125-05
NCGC00025125-06
NCGC00025125-07
NCGC00025125-08
NCGC00025125-09
NCGC00025125-10
NCGC00025125-11
NCGC00025125-12
NCGC00025125-13
NCGC00025125-14
NCGC00025125-15
NCGC00025125-18
NCGC00025125-20
NCGC00169157-01
NCGC00169157-02
NCGC00169157-03
NCGC00254359-01
NCGC00259096-01
NCGC00260995-01
NCI60_041659
NINDS_000753
NSC 757
NSC-756702
NSC-757
NSC756702
NSC757
Pharmakon1600-01500205
PL008023
Prestwick_695
Prestwick0_000363
Prestwick1_000363
Prestwick2_000363
Prestwick3_000363
RL04473
SBI-0050298.P004
SC-11404
SCHEMBL8469
SDCCGMLS-0066633.P001
SML2Y3J35T
SMR000058323
SPBio_000289
SPBio_002406
Spectrum_000842
SPECTRUM1500205
Spectrum2_000075
Spectrum3_000362
Spectrum4_000298
Spectrum5_000787
spindle poison
SR-01000597576
SR-01000597576-3
Tocris-1364
Tox21_110947
Tox21_110947_1
Tox21_201547
Tox21_300582
Tox21_500310
UNII-SML2Y3J35T
UPCMLD-DP065
UPCMLD-DP065:001
WLN: L B677 MV&T&J CO1 DO1 EO1 JMV1 NO1
ZB014630
ZINC621853
ZX-AFC000369

US Patents and Regulatory Information for COLCRYS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Takeda Pharms Usa COLCRYS colchicine TABLET;ORAL 022352-001 Jul 29, 2009 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Takeda Pharms Usa COLCRYS colchicine TABLET;ORAL 022352-001 Jul 29, 2009 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Takeda Pharms Usa COLCRYS colchicine TABLET;ORAL 022352-001 Jul 29, 2009 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Takeda Pharms Usa COLCRYS colchicine TABLET;ORAL 022352-001 Jul 29, 2009 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Paragraph IV (Patent) Challenges for COLCRYS
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Tablets 0.6 mg ➤ Subscribe 2011-12-23

Non-Orange Book US Patents for COLCRYS

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,445,541 Methods for concomitant administration of colchicine and a second active agent ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Chinese Patent Office
Accenture
Medtronic
Express Scripts
Johnson and Johnson
Boehringer Ingelheim
Dow
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.